Bio-IT World announced the winners of its Best Practices Awards competition yesterday at its annual meeting in Boston, MA. Out of the 34 projects evaluated this year, including those from industry giants GlaxoSmithKline, Amgen and Genentech, the Immune Tolerance Network’s (ITN) Clinical Trials Research Portal, TrialShare, received one of only two honorable mentions (see summary of the awards here). The Bio-IT World’s Best Practices Awards “recognize organizations for their outstanding innovations and excellence in the use of technologies and novel business strategies that will advance biomedical and translational research, drug development, and/or clinical trials.”
Mechanisms are needed to disseminate the large quantities of data associated with clinical trials in easy-to-use and intuitive formats for verification and extension of findings. The ITN developed the TrialShare Clinical Trials Research Portal (www.itntrialshare.org) to provide a single point of access to address this, along with tools and workflows to merge, analyze and review assay and clinical data, plus access bio-repository data. The system already provides the data and analysis codes that back key research findings published in the New England Journal of Medicine (NEJM), the Journal of the American Medical Association (JAMA) and the Journal of Clinical Investigation (JCI).
Those interested in exploring available data and specimens on TrialShare can create an account at www.itntrialshare.org.